GRO: A Novel Chemotactic Cytokine
Ruth Sager, Marilyn C. Pike(Bethesda Hospital), Anthony Anisowicz, Stephen Haskill(University of North Carolina at Chapel Hill), Douglas K. Trask
Cited by 24
Related Papers
A Mutation in the LDL Receptor–Related Protein 5 Gene Results in the Autosomal Dominant High–Bone-Mass Trait
|The American Journal of Human Genetics|2002|1.3k
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2
|Circulation|2002|652
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
|Annals of the Rheumatic Diseases|2013|340
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure
|Kidney International|1999|305